Oncoinvent ASA
0
0
0%

Financials

Income statement

Fiscal date Dec 2024 Sep 2024 Jun 2024 Dec 2023
Total reported revenue 681K 0 0 0
Cost of revenue 1.3M
Gross profit -1.3M
Operating expense
Research & development 22.3M 11.5M 32.0M 19.9M
Selling general and admin 937K
Other operating expenses 8.6M 5.6M 6.9M 1.1M
Operating income -33.5M -27.2M -50.8M -47.0M
Non operating interest income
Income 5.7M 4.2M 2.4M
Expense 852K 1.8M 1.4M
Other income expense
Pretax income -28.6M -24.8M -49.7M -41.3M
Tax provision 0 0 0
Net income -28.6M -24.8M -49.7M -41.3M
Basic EPS -0.5 -0.4 -0.9 -1.6
Diluted EPS -0.5 -0.4 -0.9 -1.6
Basic average shares 61.0M 61.0M 56.0M 26.5M
Diluted average shares 61.0M 61.0M 56.0M 26.5M
EBITDA -27.6M -22.9M -48.3M -41.0M
Net income from continuing op. -28.6M -24.8M -49.7M -41.3M
Minority interests
Preferred stock dividends 0 0 0 0
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 5 hours 36 minutes

10:43
00:00
09:00
16:20
23:59

Trading Hours (Monday - Friday):

Main market
09:00 - 16:20
All times are displayed in the Europe/Oslo timezone (CET, UTC+01:00).